Experience

Rhythm Pharmaceuticals Inc.

• United States
• Biotechnology Research
• 100 - 200 Employee

• Area Development Manager

  • Aug 2021 - Present



Biogen

• United States
• Biotechnology Research
• 700 & Above Employee

• Rare Disease Account Manager

  • Oct 2019 - Present

  Responsible for overall SPINRAZA (an intrathecal injection therapy for Spinal Muscular Atrophy) reimbursement, sales, formulary placement, account management, and development of sites of care. Drive alignment on procurement decisions and remove access barriers by working collaboratively with internal/external stakeholders. Engage and work strategically with C-Suite institutional leadership, HCPs, and support personnel of all potential sites of care to deliver information that facilitates patient access and reimbursement.



Acorda Therapeutics, Inc.

• United States
• Biotechnology Research
• 100 - 200 Employee

• Executive Area Business Manager

  • 2010 - 2019

  Promoted and launched Ampyra and Inbrija, which were distributed through Specialty Pharmacy contracting. Led product procurement at Specialty Pharmacies at territory Infusion Centers, V.A. Centers, Regional MS Sites of Excellence, Outpatient Rehabilitation Hospitals, Movement Disorder and MS Centers. Facilitated prior authorizations and reimbursement payments, collaborating with Market Access Team and Medical Science Liaisons. Promoted and launched Ampyra and Inbrija, which were distributed through Specialty Pharmacy contracting. Led product procurement at Specialty Pharmacies at territory Infusion Centers, V.A. Centers, Regional MS Sites of Excellence, Outpatient Rehabilitation Hospitals, Movement Disorder and MS Centers. Facilitated prior authorizations and reimbursement payments, collaborating with Market Access Team and Medical Science Liaisons.



The Medicines Company

• United States
• Pharmaceutical Manufacturing
• 200 - 300 Employee

• Critical Care Account Specialist

  • 2002 - 2010

  Launched and Promoted Angiomax and Cleviprex injectables through specialty pharmacy and buy and bill models. Cultivated relationships with decision-makers at regional hospital accounts to support clinical protocol development and care pathway placement, including demonstration the health economic impact to ensure formulary access of product portfolio. Demonstrated the health economic impact and account specific outcomes data of company products to hospital pharmacists and C-Suite leadership to ensure product access.